1. HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
- Author
-
Marcelino de Souza Durão, Thiago Corsi Filiponi, Universidade Federal de São Paulo (UNIFESP), and Hosp Israelita Albert Einstein
- Subjects
Nephrology ,medicine.medical_specialty ,medicine.medical_treatment ,urologic and male genital diseases ,Critical Care and Intensive Care Medicine ,Sepsis ,Internal medicine ,Intensive care ,medicine ,Humans ,Renal replacement therapy ,Risk factor ,Intensive care medicine ,Dialysis ,urogenital system ,business.industry ,Acute kidney injury ,Acute Kidney Injury ,medicine.disease ,female genital diseases and pregnancy complications ,Renal Replacement Therapy ,Emergency Medicine ,Cost of treatment ,dialysis ,business ,renal replacement therapy - Abstract
Sepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1). Universidade Federal de São Paulo UNIFESP, Div Nephrol, São Paulo, Brazil Hosp Israelita Albert Einstein, Renal Transplant Unit, São Paulo, Brazil Universidade Federal de São Paulo UNIFESP, Div Nephrol, São Paulo, Brazil Web of Science
- Published
- 2013